Evidence map›Paper›PMID 30755741›Full record

ArticleNature2019

Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancers.

David M Hyman, Sarina A Piha-Paul, Helen Won, Jordi Rodon, Cristina Saura, Geoffrey I Shapiro, Dejan Juric, David I Quinn, Victor Moreno, Bernard Doger and 37 more

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Negative Ultraselection of Patients WithJCO precision oncology · 2022
    Article
  9. The Evolving Landscape of HER2-Directed Breast Cancer Therapy.Current treatment options in oncology · 2020
    Review
  10. Genomic Characterization ofJCO precision oncology · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

47 authors at 10 institutions in 3 countries.

David M HymanMemorial Sloan Kettering Cancer Center, New York, New York, USA. hymand@mskcc.org.
Sarina A Piha-PaulUniversity of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
Helen WonMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Jordi RodonVall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Cristina SauraVall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Geoffrey I ShapiroDana-Faber Cancer Institute, Boston, Massachusetts, USA.
Dejan JuricMassachusetts Hospital Cancer Center, Boston, Massachusetts, USA.
David I QuinnUSC Norris Comprehensive Cancer Center, Los Angeles, California, USA.
Victor MorenoSTART Madrid Fundación Jímenez Díaz, Madrid, Spain.
Bernard DogerSTART Madrid Fundación Jímenez Díaz, Madrid, Spain.
Ingrid A MayerVanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA.
Valentina BoniSTART Madrid, Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain.
Emiliano CalvoSTART Madrid, Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain.
Sherene LoiPeter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Albert C LockhartWashington University in St. Louis School of Medicine, St Louis, Missouri, USA.
Joseph P ErinjeriMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Maurizio ScaltritiMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Gary A UlanerMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Juber PatelMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Jiabin TangMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Hannah BeerMemorial Sloan Kettering Cancer Center, New York, New York, USA.
S Duygu SelcukluMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Aphrothiti J HanrahanMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Nancy BouvierMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Myra MelcerMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Rajmohan MuraliMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Alison M SchramMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Lillian M SmythMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Komal JhaveriMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Bob T LiMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Alexander DrilonMemorial Sloan Kettering Cancer Center, New York, New York, USA.
James J HardingMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Gopa IyerMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Barry S TaylorMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Michael F BergerMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Richard E CutlerPuma Biotechnology Inc., Los Angeles, California, USA.
Feng XuPuma Biotechnology Inc., Los Angeles, California, USA.
Anna ButturiniPuma Biotechnology Inc., Los Angeles, California, USA.
Lisa D EliPuma Biotechnology Inc., Los Angeles, California, USA.
Grace MannPuma Biotechnology Inc., Los Angeles, California, USA.
Cynthia FarrellPuma Biotechnology Inc., Los Angeles, California, USA.
Alshad S LalaniPuma Biotechnology Inc., Los Angeles, California, USA.
Richard P BrycePuma Biotechnology Inc., Los Angeles, California, USA.
Carlos L ArteagaVanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA.
Funda Meric-BernstamUniversity of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
José BaselgaMemorial Sloan Kettering Cancer Center, New York, New York, USA.
David B SolitMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Memorial Sloan Kettering Cancer Center · USPuma Biotechnology (United States) · USHospital Universitario Fundación Jiménez Díaz · ESThe University of Texas MD Anderson Cancer Center · USVall d'Hebron Institute of OncologyVanderbilt-Ingram Cancer CenterDana-Farber Cancer Institute · USPeter MacCallum Cancer Centre · AUUSC Norris Comprehensive Cancer Center · USWashington University in St. Louis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 'Competing interests' statement of this Article has been updated; please see the accompanying Amendment. The original Article has not been corrected online.

Identifiers

PMID30755741
OpenAlexW2912998652

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.